Abstract CT185: First in human dose-escalation trial with the c-MET targeting antibody-drug conjugate BYON3521

Authors: N. Kotecki, C.M.L. van Herpen, C. Curigliano, M. Hendriks, T C. Vermaas, L. Corrigan, C. Belli, C. Jungels, I.M.E. Desar, N.P. Koper, J.H.M. Schellens, U. Banerji

Published: 2023-04-14

DOI: 10.1158/1538-7445.am2023-ct185

Source: Full article